Finance
Results: 433-444 of 44564

ENGWE Introduces the E26 3.0 Pro, Expanding into the Emerging eSUV Category for Smarter All-Road Riding

BlueNord Announces Second Quarter and First Half 2026 Results and Declares Cash Dividend for the Quarter

Blue Earth Therapeutics announces first participant dosed in Phase 1 clinical trial investigating Actinium (²²⁵Ac) rhPSMA-10.1 Injection in metastatic castration-resistant prostate cancer


